approval
saveYUFLYMA (ADALIMUMAB-AATY) — FDA approval
community read0 votes
Sponsor: CELLTRION. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalMay 21, 2025 · 502d ago
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalMay 21, 2025 · 502d ago
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalApr 7, 2025 · 546d ago
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalDec 23, 2024 · 651d ago
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalAug 16, 2024 · 780d ago
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalDec 22, 2023 · 1018d ago
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalDec 22, 2023 · 1018d ago
- approvalYUFLYMA (ADALIMUMAB-AATY) — FDA approvalDec 22, 2023 · 1018d ago
same company · ±60 days · 5
- approvalOSENVELT: OSENVELT (DENOSUMAB-BMWO) — FDA approvalOct 29, 2025
- approvalEYDENZELT: EYDENZELT (AFLIBERCEPT-BOAV) — FDA approvalOct 2, 2025
- approvalOSENVELT: OSENVELT (DENOSUMAB-BMWO) — FDA approvalSep 10, 2025
- approvalomalizumab biosimilar: OMLYCLO (OMALIZUMAB-IGEC) — FDA approvalDec 1, 2025
- approvalSTEQEYMA: STEQEYMA (USTEKINUMAB-STBA) — FDA approvalDec 12, 2025
comments(0)
5-min edit window · permanent after that